Co-Authors
This is a "connection" page, showing publications co-authored by Zhikang Ye and Bram Rochwerg.
Connection Strength
1.709
-
Clinical trials in COVID-19 management & prevention: A meta-epidemiological study examining methodological quality. J Clin Epidemiol. 2021 11; 139:68-79.
Score: 0.239
-
Corticosteroids in COVID-19 and non-COVID-19 ARDS: a systematic review and meta-analysis. Intensive Care Med. 2021 05; 47(5):521-537.
Score: 0.235
-
CMAJ. 2020 Nov 23; 192(47):E1571-E1584.
Score: 0.229
-
CMAJ. 2020 10 26; 192(43):E1323-E1333.
Score: 0.227
-
Remdesivir for severe covid-19: a clinical practice guideline. BMJ. 2020 07 30; 370:m2924.
Score: 0.224
-
Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis. CMAJ. 2020 07 06; 192(27):E756-E767.
Score: 0.220
-
Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence-based guideline. CMAJ. 2020 05 19; 192(20):E536-E545.
Score: 0.220
-
Prophylaxis against covid-19: living systematic review and network meta-analysis. BMJ. 2021 04 26; 373:n949.
Score: 0.059
-
Drug treatments for covid-19: living systematic review and network meta-analysis. BMJ. 2020 07 30; 370:m2980.
Score: 0.056